Ideaya Biosciences
Presença
Ideaya Biosciences é uma das ...
Ideaya Biosciences é uma empresa listada sob o símbolo IDYA (US).
Executivos
Veja o organograma con seus 17 executivos principais
Biografias mais buscadas da Ideaya Biosciences
Criar um alerta
para seguir os movimentos de executivos da Ideaya Biosciences.
Biotecnologia
Ideaya Biosciences possui 2.276 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Histogen has filed for bankruptcy protection (publicado em 19 de abril de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado em 18 de abril de 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (publicado em 16 de abril de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Ideaya Biosciences
- Investor Relations | IDEAYA Biosciences - News ReleasesBack ButtonSearch IconFilter Icon
- IDEAYA to Participate in Upcoming November 2020 Investor Relations Events - IDEAYA Biosciences
- IDEAYA Announces Partnership With The Broad Institute And Advancement Of Synthetic Lethality Programs And Platform - IDEAYA Biosciences
- IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations - IDEAYA Biosciences
- IDEAYA to Participate in Upcoming September 2020 Investor Relations Events - IDEAYA Biosciences
- IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update - IDEAYA Biosciences
- IDEAYA Announces HSR Clearance of GSK Strategic Partnership in Synthetic Lethality and Closing of Glaxo Group Equity Investment - IDEAYA Biosciences
- IDEAYA Announces IDE196 Program Update and Clinical Protocol Criteria Met for Cohort Expansion in Skin Melanoma for Phase 2 GNAQ/11 Basket Trial - IDEAYA Biosciences
- IDEAYA to Participate in Fireside Chat at BTIG Biotechnology Conference and Wedbush PacGrow Healthcare Conference on August 11 and 12, 2020 - IDEAYA Biosciences
- IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor - IDEAYA Biosciences
- View more press releases Close
Redes sociais sobre Ideaya Biosciences
- Ideaya Biosciences na Wikipedia, Google News e Yahoo Finance
- Ideaya Biosciences na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Yujiro Hata 
Ligue para a Ideaya Biosciences em +1 650...
